Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)
Completed
- Conditions
- Bronchial Cancer
- Registration Number
- NCT05605236
- Lead Sponsor
- University Hospital, Strasbourg, France
- Brief Summary
Bronchopulmonary cancer is the first cause of mortality in the world. We want to update the margins used in stereotactic radiotherapy, in the context of localized lung cancer, of non-surgical management.
The investigators wish to redefine the stereotactic radiotherapy margins according to the histological type in localized non-small cell lung cancer.
Indeed, these criteria were previously defined on a smaller cohort, in the context of 3D radiotherapy (mainly T3, T4 tumors). In addition, the incidence of radiation pneumonitis is highly dependent on the irradiated lung volume, which in turn depends on the CTV margins used.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
- Subject who has expressed opposition to participating in the study
- Impossibility to give the subject informed information (difficulties in understanding the subject, ...)
- Subject under legal protection
- Subject under guardianship or curatorship
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retrospective histological study of tumor cell dissemination around the tumor Files analysed retrospectively from January 01, 2009 to December 31, 2019 will be examined
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Service de chirurgie thoracique - CHU de Strasbourg - France
🇫🇷Strasbourg, France